تصفح
دخول
تسجيل
نسيتها؟

New Hepatitis Drug


New Hepatitis Drug

WASHINGTON (Reuters) - Bristol-Myers Squibb Co.'s. experimental drug to treat chronic hepatitis B infection showed benefits and improved liver problems, U.S. regulatory staff said in documents released on Thursday.
But Food and Drug Administration reviewers also expressed concerns over possible long-term resistance to the drug and questioned whether it posed a cancer risk.

The documents were released ahead of a panel meeting with outside experts on Friday to discuss whether the FDA should approve the drug. The agency usually, but not always, takes its panelists' advice.

Clinical trials and related studies showed the drug, known by its chemical name entecavir, "effectively reduces the (hepatitis B) viral burden," the reviewers said.

Studies also showed a number of other benefits in patients taking the drug for 48 weeks, including few major interactions with other drugs and easily adjusted doses, they said.

For more information: visit http://www.reuters.com/newsArticle.jhtml?type=healthNews&storyID=7866214

لعمرك ما ضاقت بلاد بأهلها***ولكن أخلاق الرجال تضيق

MadSurg's picture
by


it's a very good thing 2 hear that they r goin' 2 end all the scary things about HBV esp. when i hear that we have in syria about 2MILION cases of it so plz my friends go and have the free vaccine of it on every first sunday of evey month ( i don't know the name of the place but it's near the ministrey of education and u can take dawar shamaly service )even if u still in your first year cuz it's scary
and inchallah we'll c it's medicine soon and avilable 4 all and i wanna thank u very much 4 all your valuable interesting and very useful contribution soo thanks again

sopy's picture
sopy
طالب دراسات عليا
ابق على تواصل مع حكيم!
Google+